The results for the 11th Corporate Governance Evaluation has been announced on April 30, 2025. Oneness ranks among top 5% in the TPEx-listed category and the top 10% of listed companies with a market capital of 10 billion TWD or more in the non-finance and non-electronics industry, recognizing Oneness’s excellent performance and efforts in corporate governance and sustainability.
The Corporate Governance Evaluation, annually organized by Taiwan Stock Exchange and Taipei Exchange , are mainly carried out in 4 major dimensions, including “protecting shareholders’ rights,” “enhancing board structure and operation”, “increasing information transparency”, and “putting corporate social responsibility into practice”, to evaluate the performance on corporate governance. According to the organizer’s statistics, a total of 773 TPEx-listed companies were evaluated in the 11th Corporate Governance Evaluation. Based on the scores, the Evaluation was divided into seven grades, containing the top 5%, 6% -20%, 21% -35%, etc. It was a privilege for Oneness to be ranked among the top 5%. Read more about our achievement.




Oneness was selected as a component of the DJSI Emerging Markets Index, becoming the first pharmaceutical company in Taiwan to be included

2016 13th National Innovation Award, Corporate Innovation Award, Bio-pharmaceutical and New Medical Technology Group(Note)

2016 Drug Research and Development Science and Technology Award Co-Hosted by MOHW and MOEA – Bronze Medal Award(Note)

2016 Drug Research and Development Science and Technology Award Co-Hosted by MOHW and MOEA – Bronze Medal Award

2014 National Biotechnology and Medical Care Quality Award – Bronze Medal Award for Health Food Group, Nutrient Health Food Category
Note: Oneness Biotech merged with Fountain BioPharma in 2019 and inherited its rights and obligations.

In 2023, Oneness was selected as a component of the DJSI Emerging Markets Index, becoming the first pharmaceutical company in Taiwan to be included.

Oneness Biotech ranked A in MSCI ESG Rating.

The ESG performance of Oneness Biotech is recognized by FTSE Russell and has been included into FTSE4Good Index Series.

Oneness Biotech ranked the top 11th percentile among the 848 global pharmaceutical companies assessed.